Group Treatment for Self-harming Adolescents and Their Parents: a Randomized Controlled Trial
ERA
A Randomised Controlled Trial of Group Emotion Regulation for Adolescent Self-harm (the ERA-study)
4 other identifiers
interventional
180
0 countries
N/A
Brief Summary
Adolescent non-suicidal self-injury (NSSI) is common, strongly associated with psychiatric comorbidity and an increased risk of future suicide attempt. Although interventions targeting emotion regulation have been shown to reduce NSSI in both adults and adolescents few, are available within routine child and adolescent mental health services (CAMHS). Emotion Regulation for Adolescents (ERA), adapted from an evidence-based adult intervention is a brief group-based treatment designed to increase access to effective, evidence-based care for adolescents with NSSI. A large-scale randomised controlled trial (RCT) is needed to establish its efficacy and strengthen the evidence base for emotion regulation interventions for adolescent NSSI. The overall aim of this project is to increase the availability of evidence-based psychological treatments for adolescent NSSI by developing and evaluating Emotion Regulation for Adolescents (ERA), a novel behavioural and acceptance-based intervention. The main objectives are to establish the efficacy, cost-effectiveness, and long-term outcomes of ERA for adolesent NSSI in two arm RCT comparing ERA with an active control condition (FUNK) as well as to investigate potential mediators such as emotion regulation and self-criticism.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2026
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 17, 2026
CompletedFirst Posted
Study publicly available on registry
July 22, 2026
CompletedStudy Start
First participant enrolled
August 17, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2032
Study Completion
Last participant's last visit for all outcomes
December 31, 2034
July 22, 2026
July 1, 2026
6.4 years
July 17, 2026
July 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline in clinician-rated scores on Deliberate Self-Harm Inventory - Youth Version (DSHI-Y-7)
Used to assess frequency, abstinence and severity of non-suicidal self-injury. Clinician-rated. Lower scores means better outcome.
[Time Frame: Baseline; week 12 post baseline; 1 [PRIMARY ENDPOINT]-, 6- and 12-month follow-up.]
Secondary Outcomes (15)
Clinical Global Impression - Severity (CGI-S)
[Time Frame: Baseline; week 12 post baseline; 1-, 6- and 12-month follow-up.]
Clinical Global Impression - Improvement (CGI-I)
[Time Frame: Week 12 post baseline; 1-, 6- and 12-month follow-up.]
Children's Global Assessment Scale (CGAS)
[Time Frame: Baseline; week 12 post baseline; 1-, 6- and 12-month follow-up.]
Deliberate Self-Harm Inventory - Youth Version (DSHI-Y-7)
[Time Frame: Baseline; Mid-treatment: once every week (0-12 weeks post baseline); 1-, 6- and 12-month follow-up.]
Borderline Symptom List, supplement (BSL-23, suppl)
[Time Frame: Baseline; Mid- treatment: once every week (0-12 weeks post baseline); 1-, 6- and 12-month follow-up.]
- +10 more secondary outcomes
Other Outcomes (3)
Child Health Utility 9D (CHU9D)
[Time Frame: Baseline; 1- and 12-month follow-up.]
Trimbos Questionnaire for Costs associated with Psychiatric Illness (TiC-P)
[Time Frame: Baseline; 1- and 12-month follow-up.]
Negative effects questionnaire
[Time Frame: Week 6; Week 12 post baseline; 1-, 6- and 12-month follow-up]
Study Arms (2)
Emotion Regulation Adolescents (ERA).
EXPERIMENTALManualized 12-week group intervention for adolescents with NSSI and a parallel five-session parent program.
Functional habits for mental health (FUNK)
ACTIVE COMPARATORActive comparator: Active Control Condition (FUNK) Manualized psychoeducational group intervention with family participation, individualized safety planning, and weekly risk monitoring.
Interventions
Active comparator: Active Control Condition (FUNK) Participants receive a manualized active control condition FUNK consisting of: 1) ane individual family session to develop a personalized safety plan; 2) five group-based psychoeducation family sessions over 10 weeks, covering sleep, nutrition and physical activity, anxiety, depression and emotions; and 3) weekly suicide risk monitoring.
Manualized 12-week group intervention for adolescents with NSSI and a parallel five-session parent program. Experimental: ERA Participants receive ERA a 12-week manualized group intervention, targeting NSSI. The intervention focuses on increasing adaptive emotion regulation, reducing impulsive behaviours, and increasing acceptance of difficult emotions with integrated exercises to increase self-compassion and reduce self-criticism. Caregivers participate in a parallel five-session parent group focusing on preventing NSSI contagion, supporting emotion regulation and strengthening adaptive family communication and functioning.
Eligibility Criteria
You may not qualify if:
- Intellectual disability or a severe psychiatric disorder requiring immediate treatment (e.g., psychosis, bipolar disorder type 1, anorexia nervosa, alcohol/substance dependence) or conditions that prevent participation (e.g., severe social anxiety, selective mutism) Acute suicide risk (i.e., current suicide plans) or recent suicide attempt Previous or ongoing structured emotion regulation treatment involving at least 3 sessions during the past 12 months Previous or ongoing structured emotion regulation treatment (≥3 sessions within past 12 months) Social circumstances preventing participation or require immediate action (e.g., domestic violence, abuse and/or neglect in the family, inpatient care) Ongoing structured psychological treatment targeting NSSI
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karolinska Institutetlead
- Västra Götalandsregionencollaborator
- Region Stockholmcollaborator
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hanna J Sahlin, PhD, Ass Professor
Karolinska Institutet
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome assessors remain blinded to treatment allocation for all post-treatment and follow-up assessments. Identical assessment procedures and outcome measures are used accross groups to maintain blinding. Participants are reminded, at each assessment, not to disclose allocation. Assessors document any instances of accidental unblinding and and provide a guess of treatment allocation with rationale for their judgement after each assesment to evaluate blinding integrity. In cases of accidental unblinding, a new blinded assessor is assigned to conduct subsequent assessments and provide an independent treatment allocation guess. The proportion of correct guesses will be compared with chance level to assess masking success. Blinding is maintained until completion of the final follow-up assessment (12-month follow-up), and database lock, after which unblinding is performed for analysis.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Phd, Associate Professor
Study Record Dates
First Submitted
July 17, 2026
First Posted
July 22, 2026
Study Start (Estimated)
August 17, 2026
Primary Completion (Estimated)
December 31, 2032
Study Completion (Estimated)
December 31, 2034
Last Updated
July 22, 2026
Record last verified: 2026-07